Latest filing published 19 Feb 2020 for Celanese Corp, €8.9M.
Insider track record
Closed purchases
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +508.0%Entry US$2.89 · Close at T+365 US$17.58
- +139.4%Entry US$12.43 · Close at T+365 US$29.76
- +136.1%Entry US$12.20 · Close at T+365 US$28.80
- -36.4%Entry US$39.10 · Close at T+365 US$24.85
- -22.7%Entry US$38.82 · Close at T+365 US$29.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark C. Rohr: trading record in brief
Mark C. Rohr is a declared insider at 4 companies; the most frequent names are Celanese Corp, Albemarle Corp and Ashland Inc. The record holds 74 filings, for trades running from 16 February 2006 to 15 February 2020.
Both buying and selling appear: 12 purchases worth €378k, against 7 sales worth €22.7M. Sales outweigh purchases by €22.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 37 share grants and 16 option exercises.
The median purchase comes to €10k. Looking at 12 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +353.5%. Past outcomes like these are no guarantee of what comes next.
On 19 February 2020 came the latest disclosure, a share grant for €8.9M in Celanese Corp. The last insider purchase was made public on 28 November 2008, 6,554 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark C. Rohr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 87,825 shares@ US$109.58100.0% of flowCommon StockSEC:0001306830-20-000053:1
- 178,379 shares0Common StockSEC:0001306830-20-000053:0
- 94,809 shares@ US$99.9740.0% of flowCommon StockSEC:0001306830-19-000044:1
- 213,501 shares0Common StockSEC:0001306830-19-000044:0
- 30,032 shares@ US$45.385.7% of flowCommon StockSEC:0001306830-19-000032:0
- 20,095 shares@ US$99.478.4% of flowCommon StockSEC:0001306830-19-000032:1
- 42,571 shares0Common StockSEC:0001306830-19-000024:0
- 83,134 shares0Series A Common StockSEC:0001306830-18-000033:0
- 8,181 shares@ US$107.922.7% of flowSeries A Common StockSEC:0001306830-18-000009:0
- 883 shares0Common StockSEC:0001127602-17-020720:0
- 8,146 shares@ US$88.452.5% of flowSeries A Common StockSEC:0001306830-17-000069:1
- 38,834 shares0Series A Common StockSEC:0001306830-17-000069:0
- 51,902 shares@ US$78.9714.2% of flowSeries A Common StockSEC:0001306830-17-000009:0
- 25,000 shares@ US$32.682.7% of flowSeries A Common StockSEC:0001306830-16-000315:0
- 17,200 shares@ US$69.503.9% of flowSeries A Common StockSEC:0001306830-16-000315:1
- 247,218 sharesSeries A Common StockSEC:0001306830-16-000217:0
- 51,854 sharesSeries A Common StockSEC:0001306830-16-000217:1
- 106,068 sharesSeries A Common StockSEC:0001306830-16-000194:0
- 44,512 sharesSeries A Common StockSEC:0001306830-16-000194:1
- 9,264 shares@ US$55.54Series A Common StockSEC:0001306830-15-000041:0
- 106,066 shares0Series A Common StockSEC:0001306830-15-000021:0
- 44,442 shares@ US$53.74Series A Common StockSEC:0001306830-15-000021:1
- 6,021 shares@ US$42.20Series A Common StockSEC:0001306830-13-000039:0
- 5,823 shares@ US$38.08Series A Common StockSEC:0001306830-12-000147:0
- 66,108 shares0Series A Common StockSEC:0001140361-12-019840:0
25 of 74 declarations
